Jonathan Seaton:
Non-executive Director

Jonathan Seaton, Non-executive Director

Jonathan has 25 years of experience working for leading global life sciences and diagnostic companies and has worked on more than 50 merger and acquisition transactions in his career, including seven years at Roche Diagnostics (2008-2015), where he held the position of Vice Director, Global Business Development, advising leading merger and acquisition activity and strategic partnerships. He then moved to Becton, Dickinson and Company in 2015 where he focused on key strategic programmes, followed by Illumina in 2017 where he was Head of Corporate and Business Development and Government Affairs.

Jonathan is currently the Head of Corporate Business Development at Bio-Rad. Prior to Roche Diagnostics, he worked as a life sciences investment banker for Deutsche Bank Securities.